We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-18.55%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$656M
AUM Growth
+$127M
Cap. Flow
-$219M
Cap. Flow %
-33.35%
Top 10 Hldgs %
78.61%
Holding
100
New
17
Increased
8
Reduced
19
Closed
46

Top Buys

Rank Stock Value
1
ATEC icon
Alphatec Holdings
ATEC
+$3.65M
2
EVH icon
Evolent Health
EVH
+$1.83M
3
DVA icon
DaVita
DVA
+$1.15M
4
MYGN icon
Myriad Genetics
MYGN
+$865K
5
CHWY icon
Chewy
CHWY
+$808K

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$21.6M
2
KVUE icon
Kenvue
KVUE
+$9.06M
3
NTRA icon
Natera
NTRA
+$7.75M
4
QTRX icon
Quanterix
QTRX
+$7.3M
5
MTD icon
Mettler-Toledo International
MTD
+$7.2M

Sector Composition

Rank Sector Weight
1 Healthcare 63.58%
2 Consumer Discretionary 0.15%
3 Consumer Staples 0%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUTR
26
DELISTED
Cutera, Inc.
CUTR
$3.77M 0.58%
1,070,494
-179,639
-14% -$547K
LNTH icon
27
CALL
Lantheus
LNTH
$6.57B
$3.73M 0.57%
60,200
+22,800
+61% +$1.54M
ELAN icon
28
Elanco Animal Health
ELAN
$11.4B
$3.43M 0.52%
230,000
-215,914
-48% -$2.45M
DXCM icon
29
DexCom
DXCM
$33.8B
$3.25M 0.5%
26,157
+7,757
+42% +$792K
NTRA icon
30
CALL
Natera
NTRA
$45.1B
$3.02M 0.46%
+48,200
New +$2.41M
PODD icon
31
Insulet
PODD
$10B
$2.71M 0.41%
12,500
+2,500
+25% +$429K
GH icon
32
CALL
Guardant Health
GH
$22.2B
$2.71M 0.41%
+100,000
New +$2.62M
STAA icon
33
PUT
STAAR Surgical
STAA
$1.24B
$2.42M 0.37%
77,500
+7,500
+11% +$269K
TNDM icon
34
CALL
Tandem Diabetes Care
TNDM
$1.63B
$2.22M 0.34%
+75,000
New +$1.56M
QTRX icon
35
CALL
Quanterix
QTRX
$124M
$2.19M 0.33%
80,000
-20,000
-20% -$471K
EVH icon
36
Evolent Health
EVH
$464M
$2.13M 0.33%
+64,573
New +$1.83M
INSP icon
37
Inspire Medical Systems
INSP
$1.71B
$2.03M 0.31%
10,000
-30,487
-75% -$4.94M
LIVN icon
38
CALL
LivaNova
LIVN
$4.33B
$1.54M 0.23%
29,700
-216,100
-88% -$10.5M
IMDX
39
Insight Molecular Diagnostics
IMDX
$145M
$1.47M 0.22%
586,930
-71,191
-11% -$219K
SOPH icon
40
SOPHiA GENETICS
SOPH
$638M
$1.34M 0.2%
284,724
– –
DVA icon
41
DaVita
DVA
$11.4B
$1.31M 0.2%
+12,500
New +$1.15M
ESTA icon
42
CALL
Establishment Labs
ESTA
$2.21B
$1.29M 0.2%
50,000
-9,900
-17% -$290K
NSPR icon
43
InspireMD
NSPR
$39.9M
$1.27M 0.19%
450,517
+94,326
+26% +$272K
MSOS icon
44
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
$1.25M 0.19%
178,309
-150,000
-46% -$997K
CHWY icon
45
Chewy
CHWY
$9.2B
$969K 0.15%
+41,000
New +$808K
MYGN icon
46
Myriad Genetics
MYGN
$308M
$957K 0.15%
+50,000
New +$865K
CUTR
47
CALL
DELISTED
Cutera, Inc.
CUTR
$705K 0.11%
200,000
+50,000
+33% +$152K
NYXH
48
Nyxoah
NYXH
$159M
$523K 0.08%
111,467
– –
GH icon
49
Guardant Health
GH
$22.2B
$406K 0.06%
15,000
-7,943
-35% -$208K
APYX icon
50
Apyx Medical
APYX
$127M
$210K 0.03%
80,000
-756,990
-90% -$1.83M
1
2
3 4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Pura Vida Investments held 100 positions worth $656M, up 24% from $529M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Pura Vida Investments withdrew a net $219M in Q4 2023, closing 46 positions and reducing 19 holdings. Its most notable exit was Glaukos, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in Alphatec Holdings worth $4.61M.

  • Pura Vida Investments's largest Q4 2023 buy was Alphatec Holdings: 305,000 shares worth $4.61M.
  • Pura Vida Investments added most to DexCom in Q4 2023, an estimated $792K increase.
  • Pura Vida Investments's biggest Q4 2023 reduction was Natera, cutting an estimated $7.75M.
  • Pura Vida Investments fully exited Glaukos in Q4 2023, selling an estimated $21.6M.
  • Pura Vida Investments's ten largest holdings make up 79% of its $656M portfolio in Q4 2023.
  • Pura Vida Investments opened 17 new positions and closed 46 in Q4 2023.
  • Pura Vida Investments's portfolio value rose 24% quarter-over-quarter to $656M.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.